How much Vitamin D is needed varies

From Routine Supplementation to Targeted Repletion: Vitamin D Deficiency in UVB-Constrained, Pollution-Exposed, and Ageing Populations—Musculoskeletal and Extra-Skeletal Perspectives

Nutrients, 21 August 2026, https://doi.org/10.3390/nu18162736

Yonghyun Yoon, Jihyo Hwang, Jungyoun Kim, Ki-Tae Kim, Chan-Mo Yang, Rowook Park, Jaehyun Shim, Jonghyeok Lee, Seungbeom Kim, Youngmo Kim, King Hei Stanley Lam

Table of contents (condensed)

image

image

Summary by Claude Opus 5 - August, 2026

Correcting a documented deficiency and handing fixed-dose pills to everyone are two different interventions, and this review argues the vitamin D literature keeps scoring one using trials of the other. It is a narrative review — no PRISMA counts, no risk-of-bias scoring, no pooled estimates — from a Korean orthopedic and pain group, with a literature cutoff of 30 June 2026.

The strongest case for repletion stays musculoskeletal: osteomalacia, muscle weakness, sarcopenia, falls, and support of osteoporosis treatment. Cardiovascular, cancer, mood, sleep, and pain links are treated as observational or mechanistic only.

On why the large trials read neutral: in VITAL the median baseline 25(OH)D was about 31 ng/mL, so few participants were deficient; fixed doses raise levels less in heavier bodies; endpoints like cancer incidence need long latency; and bolus dosing behaves unlike daily. Key figures cited: a 2026 BMJ meta-analysis of 69 RCTs and 153,902 adults found vitamin D alone gave RR 1.00 for any fracture, and calcium+D gave RR 0.91 but with absolute effects the authors judged below clinical importance. An individual-patient meta-analysis of 14 trials and 104,727 people found cancer mortality RR 0.94 overall, 0.88 with daily dosing, 1.07 with boluses.

Doses discussed: maintenance 800–2,000 IU/day; 6,000 IU/day for 4–12 weeks when rapid correction is indicated; 1,000 IU/day, 7,000 IU/week and 30,000 IU/month biochemically equivalent. A single 100,000 IU intramuscular dose left roughly half of recipients still deficient at 4 weeks (mean 28.4 ng/mL).

What this does not show: no new data, no systematic search, and no test of whether targeted repletion actually improves outcomes — that remains the unproven hypothesis. The authors treat ≥20 ng/mL as adequate for most people and call 50–80 ng/mL targets investigational.

PDF


Related in VitaminDWiki

Obese

Dark Skin

Response

Microplastics

50 ng

Stressors which often require larger Vitamin D dosing

Click on a tag to see studies: How much (288) Vitamin D (11,512)